홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

N-[(Phenylmethoxy)carbonyl]-L-isoleucine → 2-(2-Methoxyphenyl)-8-(1-methylethyl)-5,6,7,8-tetrahydro-imidazo[1,2-a]pyrazine

HRID 901121
인쇄

반응식

HRID 901121 반응식
[CH2:1]([CH:5]1[N:10](C(=O)CCC2NC=NC=2)[CH2:9][CH2:8][N:7]2[CH:20]=[C:21]([C:23]3[CH:28]=[CH:27][CH:26]=[CH:25][C:24]=3[O:29][CH3:30])[N:22]=[C:6]12)[CH2:2]CC.N(C(OCC1C=CC=CC=1)=O)[C@H:32](C(O)=O)[C@H](CC)C>>[CH3:30][O:29][C:24]1[CH:25]=[CH:26][CH:27]=[CH:28][C:23]=1[C:21]1[N:22]=[C:6]2[CH:5]([CH:1]([CH3:32])[CH3:2])[NH:10][CH2:9][CH2:8][N:7]2[CH:20]=1
참가 물질실험 절차출처 및 근거반응 노트

참가 물질

3

반응물 2

HCID 2724772N-[(Phenylmethoxy)carbonyl]-L-isoleucineHCID 229282328-Butyl-7-(3-(imidazol-5-yl)-1-oxopropyl)-2-(2-methoxyphenyl)-5,6,7,8-tetrahydroimidazo[1,2-a]pyrazine

생성물 1

HCID 220168112-(2-Methoxyphenyl)-8-(1-methylethyl)-5,6,7,8-tetrahydro-imidazo[1,2-a]pyrazine

실험 절차

through 5.g. were carried out in a manner analogous to Steps 1.c. through 1.f of example 1, starting with Cbz-(L)-Ile-OH in place of Cbz-(L)-Nle-OH, and yielding 2-(2-methoxyphenyl)-8-(1-methylethyl)-5,6,7,8-tetrahydro-imidazo[1,2-a]pyrazine (compound vii, where R3 is isobutyl, R4 is 2-methoxyphenyl and R5, R6, and R7 are H,).

출처 및 근거

ORD 기록
ord-fd194f83054845be845d9089738671af
출처 데이터셋
uspto-grants-2008_04
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US07361656B2

반응 노트

이 페이지에서참가 물질실험 절차출처 및 근거반응 노트